Corporate
  • Astellas Pharma

    Created in 2005
  • Social networks

    509,818 42,723 42,723
  • Sectors

  • Location

    Nihombashi Astellas Mitsui Bldg., 2-chōme-5-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023, Japan

    Chuo City

    Japan

  • Engaged entities

    122
    87 23
  • Added in Motherbase

    17 Jul 2024, 2:43 p.m.
Description
  • Value proposition

    Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world.

    At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

    Pharmaceuticals and 医薬品

Entity interactions BETA
Entity TypeTweets Articles
EQT Life Sciences EQT Life Sciences
Venture Capital and Private Equity Principals
Other

30 Sep 2024


ImCheck Therapeutics ImCheck Therapeutics
biotech, deeptech, Biotechnology Research
Other

30 Nov 2024


Clinique Belharra Clinique Belharra
healthtech
Other

29 Nov 2024


Parkwalk Advisors Parkwalk Advisors
Venture Capital and Private Equity Principals
Other

2 Dec 2024


Prostate Cancer Foundation of Australia Prostate Cancer Foundation of Australia
biotech, healthtech, Non-profit Organizations
Other

27 Nov 2024


Soleterre Soleterre
healthtech, Civic and Social Organizations
Other

30 Sep 2024


Salud35 Salud35
Newspaper Publishing
Other

28 Nov 2024


Cambridge Chamber of Commerce (USA) Cambridge Chamber of Commerce (USA)
martech, Civic and Social Organizations
Other

30 Sep 2024


Fundació Puigvert Fundació Puigvert
healthtech
Other

29 Oct 2024


PharmaVoice PharmaVoice
Pharmaceutical Manufacturing
Other

13 Nov 2024


Radars
Loading...